EUVIMEDEUVIMED entdecken
Crossref

Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells In Vivo

Arnab Kumar Sahoo, Antara Mondal, Faisal Jamal, Arpita Das, Khushboo Chaudhary, Aakriti Jha, Tarandeep Singh Bansal, Pritam Mandal, Ashis Kumar Dhara, Yang Yang, Santiswarup Singha iD

Nano Letters · 09.07.2025 · 25 (27) · 10817-10825

DOI: 10.1021/acs.nanolett.5c02012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 24.06.2025. Verfasst von Arnab Kumar Sahoo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nano-Biotechnology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Antigen-Presenting Cells, Peptides, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Indian Council of Medical Research, Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesAntigen-Presenting CellsPeptidesNeoplasmsAnimalsMiceMajor Histocompatibility ComplexMice, Inbred C57BLAntigens, NeoplasmHumansCell Line, TumorReceptors, Antigen, T-CellImmunotherapy, Adoptive

Stichwörter der Autor:innen

Antitumor therapeutic efficacyArtificial antigen-presenting cellsIn vivo expansion of endogenous CD8+ T-cellsTumor antigen-specific CD8+ T-cellsValency of p-MHC

Substanzen

PeptidesAntigens, NeoplasmReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Nano-Biotechnology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India.
  • Department of Electrical Engineering, National Institute of Technology-Durgapur, Mahatma Gandhi Avenue, Durgapur, West Bengal 713209, India.
  • TANLUN Medical Research and Innovation Inc., #6, XIERQIZHONGLU, Haidian District, Beijing 80086, China.

ORCID-Profile: Santiswarup Singha

Förderung

  • Indian Council of Medical Research
  • Science and Engineering Research Board
  • Department of Biotechnology, Ministry of Science and Technology, India
  • National Institute of Immunology

Zitieren

APA

Sahoo, A. K., Mondal, A., Jamal, F., Das, A., Chaudhary, K., Jha, A., Bansal, T. S., Mandal, P., Dhara, A. K., Yang, Y., & Singha, S. (2025). Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells In Vivo. Nano Letters, 25(27), 10817-10825. https://doi.org/10.1021/acs.nanolett.5c02012

Vancouver

Sahoo AK, Mondal A, Jamal F, Das A, Chaudhary K, Jha A, et al. Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells In Vivo. Nano Letters. 2025;25(27):10817-10825. doi:10.1021/acs.nanolett.5c02012

BibTeX
@article{Sahoo2025,
  author = {Sahoo, Arnab Kumar and Mondal, Antara and Jamal, Faisal and Das, Arpita and Chaudhary, Khushboo and Jha, Aakriti and Bansal, Tarandeep Singh and Mandal, Pritam and Dhara, Ashis Kumar and Yang, Yang and Singha, Santiswarup},
  title = {Defining the Critical Valency of Peptide-MHC on Nanoscale Artificial Antigen Presenting Cells for Expanding Endogenous Tumor-Specific T-cells In Vivo},
  journal = {Nano Letters},
  year = {2025},
  volume = {25},
  number = {27},
  pages = {10817--10825},
  doi = {10.1021/acs.nanolett.5c02012}
}
Kostenlos starten →